Dow Up 0.08% Nasdaq Down 0.30%

Agenus Inc. (AGEN)

-NasdaqCM
2.92 Down 0.06(2.01%) Sep 19, 4:00PM EDT
Prev Close:2.98
Open:2.95
Bid:2.50 x 300
Ask:3.04 x 2100
1y Target Est:6.00
Beta:2.16
Next Earnings Date:N/A
Day's Range:2.88 - 3.02
52wk Range:2.27 - 5.27
Volume:604,066
Avg Vol (3m):874,089
Market Cap:183.02M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 2.01%183.02M
ABPIDown 25.00%134.63K
DNDNUp 5.63%233.14M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback